ARVO Foundation names first Vogel Pharmaceutical Award recipient
The ARVO Foundation for Eye Research recognizes Naj Sharif, PhD, as the first recipient of the Dr. Roger Vogel Award for Pharmaceutical Research for his work in the developments of pharmaceutical treatments for ophthalmic diseases. The award was created in honor of Dr. Roger Vogel, who has been in the ophthalmic pharmaceutical business for almost 30 years and has led the development of many of the medicines now used by ophthalmologists.
Researchers collaborate to reduce effects of the aging eye
In a special issue of Investigative Ophthalmology & Visual Science (IOVS)
, ophthalmic leaders from around the world address “the aging eye” to focus attention on unmet needs and accelerate the translation of research findings into effective clinical care.
Trained airport checkpoint screeners miss rare targets
According to a new study published in the Journal of Vision
, the low frequency at which trained airport screeners find threats reduces the chances targets will be found
Contact lens discomfort: what is it, why does it occur and how can it be treated?
Contact lens discomfort (CLD) may be the leading cause of patient dissatisfaction with, and discontinuation of, contact lens wear throughout the world — but there is little agreement among vision researchers and eye care professionals about how to define and manage its causes.
Vision community to host four congressional events this fall
The Alliance for Eye and Vision Research (AEVR)
, a 501(c)3 non-profit foundation, is proud to announce these educational programs associated with its Decade of Vision 2010-2020 Initiative, a sustained educational effort acknowledged by Congress that recognizes the benefits of federally funded vision research.
ARVO Board of Trustees names new student/trainee member
The Association for Research in Vision and Ophthalmology (ARVO) Board of Trustees has appointed Megan Capozzi of Vanderbilt Eye Institute, Vanderbilt University to be the new At-large Members-in-Training (MIT) Board member.
New software provides free framework for collaborative research in visual field analysis
Vision researchers have developed new software that will analyze visual fields in an open-source platform to improve and encourage collaborative research among independent labs.
ARVO immediate past president knighted in U.K. Queen’s Birthday Honors
ARVO Immediate Past President Peng Tee Khaw, MD, PhD, FARVO, is the first member of the Association for Research in Vision and Ophthalmology (ARVO) to be knighted in the Queen’s birthday honors.
Smith begins term as ARVO president
Justine Smith, FRANZCO, PhD, FARVO (Flinders University) is the new president of the Association for Research in Vision and Ophthalmology (ARVO). She succeeds Peng T. Khaw, MD, PhD, FARVO (Moorfields Eye Hospital and UCL Institute of Ophthalmology), whose one-year term ended this month following the ARVO Annual Meeting.
2013 Achievement Award Recipients Honored at Annual Meeting
The Association for Research in Vision and Ophthalmology (ARVO) is pleased to announce its 2013 Achievement Award recipients. These award recipients will be acknowledged at the ARVO 2013 Annual Meeting, May 5 – 9, in Seattle, Wash.
Announcing three special sessions during ARVO 2013 Annual Meeting
ARVO is pleased to host three special sessions during the 2013 Annual Meeting (May 5 – 9) in Seattle, Wash. These sessions will take place at the Washington State Convention Center.
ARVO Foundation congratulates 2012 Vistakon Fellowship recipients
The ARVO Foundation for Eye Research announces Geraint John Parfitt, BSc, PhD and Jerome Gabriel Mauris, PhD, as recipients of the 2012 Vistakon Dry Eye Research. Each received $40,000 to support their basic research of meibomian gland dysfunction (MGD) and dry eye disease.
ARVO Foundation announces 2012 Genentech Fellowship recipients
The ARVO Foundation for Eye Research congratulates the 2012 recipients of the Genentech Age-related Macular Degeneration Research Fellowships – Venkata Chavali, MSc, PhD and Helder A.M.B. André, PharmD, PhD. Each received $40,000 to support their age-related macular degeneration (AMD) research.
Three distinguished keynote speakers to present during ARVO 2013 Annual Meeting
The ARVO 2013 Annual Meeting will feature lectures from three keynote speakers, including two Nobel laureates, during the organization’s five-day conference, May 5 – 9 in Seattle, Wash.
Treating eye diseases with anti-VEGF therapies may have side effects
A new IOVS
article reveals that increasingly aggressive therapies that block VEGF might have a harmful effect on the tissue responsible for producing the fluid that bathes the eye, medically termed the ciliary body.
Fear of falling may cause social isolation in older adults with vision problems
A new study published in Investigative Ophthalmology & Visual Science
found that between 40 to 50 percent of older adults with visually impairing eye disease limit their activities due to a fear of falling.
Glaucoma study could inspire e-reader apps
According to a new scientific study published in Investigative Ophthalmology & Visual Science
, adults with glaucoma read slower when reading silently for long periods of time and are more likely to have their reading speed decrease over time.
Forum to bring together leading-edge ophthalmic researchers and investors
Thenewest ophthalmic innovations with market potential will be the focus of aone-day seminar in Seattle on May 3, 2013 that will connect scientists, venturecapitalists, pharmaceutical representatives and others.
Smoking may lead to cataracts in aging population
Cigarette smoking is a well-known risk factor for a wide-range of diseases. Now, scientists have evidence that smoking may also increase the risk of age-related cataract, the leading cause of blindness and vision loss in the world.
New study links caffeinated coffee to vision loss
According to a scientific paper in Investigative Ophthalmology & Visual Science
, heavy caffeinated coffee consumption is associated with an increased risk of developing exfoliation glaucoma, the leading cause of secondary glaucoma worldwide.